‘Failure for humanity’: rich world aims to end vaccine inequities



To date, some 1.53 billion doses have been administered globally, but only around 1% of them in Africa, according to the World Health Organization (WHO). However, Pfizer (PFE.N) and BioNTech pledged to make available 1 billion cut-price doses this year to poorer nations. Another 1 billion vaccines would be provided next year, Pfizer boss Albert Bourla said. read moreJohnson & Johnson (JNJ.N) promised 200 million doses of its vaccine to COVAX, a vaccine-sharing programme co-led by the WHO. The COVAX program, which is dedicated to equitable global vaccine distribution, was also mentioned as a way of providing donated doses to countries.


65.32% objective
55.28% positive


NEW YORK POST - COVID fight could return ‘to square one’: experts sound vaccines alarm
-15.69% LESS objective
0.07% MORE positive

It was already around 100 million doses short of where it had planned to be when India halted exports a month ago amid a surge in infections there. She and others said it was imperative that wealthy countries and regions make good on their rhetoric and share excess vaccines now. It has so far distributed about 65 million doses of mainly the AstraZeneca COVID-19 vaccine, many of them to Africa. A spokeswoman for the GAVI vaccines alliance, which co-leads COVAX, said the facility was working hard to make up supplies. Vaccine sharing announced by EU member states has so far amounted to 11.1 million vaccines, he said, of which 9 million are being shared via COVAX.

DAILY MAIL - Vaccine makers pledge 2.3B doses to less wealthy nations
-2.22% LESS objective
-6.04% LESS positive

Pfizer and German partner BioNTech pledged Friday to deliver two billion doses of their COVID-19 vaccine to middle- and low-income countries over the next 18 months, amid international calls for more vaccine solidarity. Pfizer CEO Albert Bourla said they expect to provide a billion of the doses this year and another billion in 2022. He has previously said the firm will deliver six billion doses worldwide in the next 18 months - meaning two-thirds will go to wealthier nations. And Pfizer made $3.46 billion in COVID-19 vaccine sales in the first quarter of 2021 alone, the firm disclosed earlier this month. During Friday's global health summit in Rome, Italian Premier Mario Draghi said that nearly 1.5 billion vaccine doses have been administered in over 180 countries worldwide.

WIRED - Vaccine Deals for Countries in Need, a Surge in Japan, and More Coronavirus News
-13.52% LESS objective
-0.47% LESS positive

Drugmakers strike new vaccine deals, the EU expands travel policies, and Japan fights a new surge. HeadlinesDrugmakers agree to provide vaccine doses to countries in needPfizer and BioNTech pledged earlier today to give 1 billion doses of their Covid vaccine to low- and middle-income countries by the end of this year, and another billion over the course of 2022. This week, President Biden also announced that the US will donate more of its vaccine surplus. Stateside, government officials have reportedly been weighing the possibility of changing the US’s travel policies surrounding Covid. In response, Hong Kong and Singapore have changed their travel policies, Malaysia has imposed a new lockdown, and many people across the region have retreated to their homes.

REUTERS - EXCLUSIVE Latin America poised to benefit as U.S. raises exports of COVID-19 shots -sources
-0.89% LESS objective
4.4% MORE positive

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Many Latin American countries have a dire need for COVID-19 vaccines as they combat outbreaks. Recent recipients of Pfizer's U.S.-made vaccine doses include Brazil, Costa Rica, Ecuador, Peru, and Uruguay, the person added. Republican Senator and former presidential candidate Mitt Romney on Thursday urged the United States to speed up global vaccination sharing to better compete with global rivals. The United States is becoming a top supplier of COVID-19 shots to the world as the success of its own vaccination campaign has led to reduced demand at home.